Cargando…

Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells

A pH-triggered mesoporous silica nanoparticle (MSN)-based nano-vehicle for the dual delivery of doxorubicin (DOX)/camptothecin-PEG (CPT-PEG) has been prepared. To enhance its selectivity, the nanoparticles were decorated with glycyrrhetinic acid (GA) to target HepG2 cells. The highly insoluble CPT w...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Edo, Gabriel, Fornaguera, Cristina, Borrós, Salvador, Sánchez-García, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694026/
https://www.ncbi.nlm.nih.gov/pubmed/33147860
http://dx.doi.org/10.3390/pharmaceutics12111048
_version_ 1783614881407172608
author Martínez-Edo, Gabriel
Fornaguera, Cristina
Borrós, Salvador
Sánchez-García, David
author_facet Martínez-Edo, Gabriel
Fornaguera, Cristina
Borrós, Salvador
Sánchez-García, David
author_sort Martínez-Edo, Gabriel
collection PubMed
description A pH-triggered mesoporous silica nanoparticle (MSN)-based nano-vehicle for the dual delivery of doxorubicin (DOX)/camptothecin-PEG (CPT-PEG) has been prepared. To enhance its selectivity, the nanoparticles were decorated with glycyrrhetinic acid (GA) to target HepG2 cells. The highly insoluble CPT was derivatized with a reductive-cleavable PEG chain to improve its loading within the MSN. The preparation of these particles consisted of four steps. First, CPT-PEG was loaded within the pores of the MSN. Then, dihydrazide polyethylene glycol chains were introduced onto the surface of an aldehyde-functionalized MSN by means of a hydrazone bond. Afterwards, DOX was covalently attached to the other end of the dihydrazide polyethylene glycol chains. Finally, the resulting nanoparticles were decorated with GA by formation of an imine bond between the amino group of DOX and a benzaldehyde-GA derivative. The system was stable at physiological conditions and the release of both drugs was negligible. However, at acidic pH, a burst release of DOX and a gradual release of CPT-PEG takes place. GA-decorated drug delivery systems (DDS) selectively internalizes into HepG2. In vitro tests demonstrated that this system shows a great cytotoxicity towards HepG2 cells. Furthermore, glutathione cleavage of CPT prodrug assures the formation of free CPT leading to a synergistic effect in combination with DOX.
format Online
Article
Text
id pubmed-7694026
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76940262020-11-28 Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells Martínez-Edo, Gabriel Fornaguera, Cristina Borrós, Salvador Sánchez-García, David Pharmaceutics Article A pH-triggered mesoporous silica nanoparticle (MSN)-based nano-vehicle for the dual delivery of doxorubicin (DOX)/camptothecin-PEG (CPT-PEG) has been prepared. To enhance its selectivity, the nanoparticles were decorated with glycyrrhetinic acid (GA) to target HepG2 cells. The highly insoluble CPT was derivatized with a reductive-cleavable PEG chain to improve its loading within the MSN. The preparation of these particles consisted of four steps. First, CPT-PEG was loaded within the pores of the MSN. Then, dihydrazide polyethylene glycol chains were introduced onto the surface of an aldehyde-functionalized MSN by means of a hydrazone bond. Afterwards, DOX was covalently attached to the other end of the dihydrazide polyethylene glycol chains. Finally, the resulting nanoparticles were decorated with GA by formation of an imine bond between the amino group of DOX and a benzaldehyde-GA derivative. The system was stable at physiological conditions and the release of both drugs was negligible. However, at acidic pH, a burst release of DOX and a gradual release of CPT-PEG takes place. GA-decorated drug delivery systems (DDS) selectively internalizes into HepG2. In vitro tests demonstrated that this system shows a great cytotoxicity towards HepG2 cells. Furthermore, glutathione cleavage of CPT prodrug assures the formation of free CPT leading to a synergistic effect in combination with DOX. MDPI 2020-11-02 /pmc/articles/PMC7694026/ /pubmed/33147860 http://dx.doi.org/10.3390/pharmaceutics12111048 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Martínez-Edo, Gabriel
Fornaguera, Cristina
Borrós, Salvador
Sánchez-García, David
Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells
title Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells
title_full Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells
title_fullStr Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells
title_full_unstemmed Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells
title_short Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells
title_sort glycyrrhetinic acid-functionalized mesoporous silica nanoparticles for the co-delivery of dox/cpt-peg for targeting hepg2 cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694026/
https://www.ncbi.nlm.nih.gov/pubmed/33147860
http://dx.doi.org/10.3390/pharmaceutics12111048
work_keys_str_mv AT martinezedogabriel glycyrrhetinicacidfunctionalizedmesoporoussilicananoparticlesforthecodeliveryofdoxcptpegfortargetinghepg2cells
AT fornagueracristina glycyrrhetinicacidfunctionalizedmesoporoussilicananoparticlesforthecodeliveryofdoxcptpegfortargetinghepg2cells
AT borrossalvador glycyrrhetinicacidfunctionalizedmesoporoussilicananoparticlesforthecodeliveryofdoxcptpegfortargetinghepg2cells
AT sanchezgarciadavid glycyrrhetinicacidfunctionalizedmesoporoussilicananoparticlesforthecodeliveryofdoxcptpegfortargetinghepg2cells